Article ISI
JOURNAL OF CLINICAL ONCOLOGY  (2021)

Survival impact among occidental patients with metastatic gastric cancer (mGC) treated with ramucirumab as second line treatment (2L): Local experience of a teaching hospital in Chile.

Salinas, Carlos; BARAJAS-BARAJAS, OLGA BEATRIZ; Villanueva, Luis

Más información

Título según WOS: Survival impact among occidental patients with metastatic gastric cancer (mGC) treated with ramucirumab as second line treatment (2L): Local experience of a teaching hospital in Chile.
Título de la Revista: JOURNAL OF CLINICAL ONCOLOGY
Volumen: 39
Editorial: LIPPINCOTT WILLIAMS & WILKINS
Fecha de publicación: 2021
DOI:

10.1200/JCO.2021.39.15_SUPPL.E16007
Notas: ISI